SAM
AMLX icon

Sectoral Asset Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Sectoral Asset Management’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-84,055
Closed -$1.24M – 95
2023
Q4 		$1.24M Buy
84,055
+10,400
+14% +$159K 0.53% 61
2023
Q3 		$1.35M Sell
73,655
-313,655
-81% -$6.63M 0.26% 97
2023
Q2 		$8.35M Buy
387,310
+144,910
+60% +$3.91M 1.39% 24
2023
Q1 		$7.11M Buy
242,400
+84,450
+53% +$2.93M 1.37% 24
2022
Q4 		$5.84M Sell
157,950
-47,450
-23% -$1.68M 1.13% 36
2022
Q3 		$5.78M Buy
+205,400
New +$5.12M 1.14% 34

Other funds holding AMLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Sectoral Asset Management's AMLX Position: Q1 2024 in Review

Sectoral Asset Management sold out of Amylyx Pharmaceuticals (AMLX) in Q1 2024, closing a stake of 84,055 shares — an estimated $1.24M sold.

Sectoral Asset Management first reported a position in AMLX in Q3 2022 and held it in 6 quarters. The position peaked at $8.35M in Q2 2023. 143 funds tracked by Wall St. Rank hold AMLX as of Q1 2024.

  • Sectoral Asset Management reported no remaining Amylyx Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Sectoral Asset Management sold 84,055 Amylyx Pharmaceuticals shares in Q1 2024, an estimated $1.24M.
  • Sectoral Asset Management first reported a position in Amylyx Pharmaceuticals in Q3 2022 and held it in 6 quarters.
  • Sectoral Asset Management's Amylyx Pharmaceuticals position peaked at $8.35M in Q2 2023.
  • 143 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2024.

Based on Sectoral Asset Management's 13F filing for Q1 2024, filed 14 May 2024.